Laatst bijgewerkt: 19 december, 2023
Persbericht van ons hoofdkantoor in Parijs
In November, everyone’s taking action to support the fight against pancreatic and gastric cancers
Suresnes (France), November 16, 2023 – Faced with the growing need for therapeutic solutions for patients, we have made oncology one of our priorities at Servier. Our ambition is to become a focused and innovative player developing therapies to treat cancer. Two events during the month of November highlight our commitment: World Pancreatic Cancer Day and Gastric Cancer Awareness Month, which seek to raise awareness about stomach cancer.
For World Pancreatic Cancer Day on November 16, we are supporting various initiatives including the World Pancreatic Cancer Coalition campaign.
Collective intelligence, an innovative approach to treating pancreatic cancer?
To accelerate research and development for innovative treatments, we are rolling out a strong approach to open innovation with pharmaceutical companies, biotechnology companies, prestigious academic institutions and startups. In terms of oncology, we have established more than 40 partnerships and research collaborations.
How can we improve the lives of gastric cancer patients?
By working with patients, we seek to answer this question. In this context, we launched the SHAPE2 international program in collaboration with Digestive Cancers Europe. We have published a number of brochures and videos co-created with patient- experts, patient representatives, caretakers, oncologists, other health care professionals and nurses. These materials are designed for patients living with digestive cancers to support them, as well as their family, throughout their cancer journey.